Preprint · OA
via OpenAlex
Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers
Utkarsh Tripathi, Masayoshi Suda, Vagisha Kulshreshtha, Bryan Thomas Piatkowski, Allyson K. Palmer, Nino Giorgadze, Christina L. Inman, Nathan S. Gasek, Ming Xu, Kurt O. Johnson, Tamar Pirtskhalava, Selim Chaib, Larissa G. P. Langhi Prata, Yi Zhun Zhu, Renuka Kandhaya‐Pillai
bioRxiv (Cold Spring Harbor Laboratory) · 2025
Abstract
Abstract The senescent cell (SC) fate is linked to aging, multiple disorders and diseases, and physical dysfunction. Senolytics(definition), agents that selectively eliminate 30-70% of SCs, act by transiently disabling the senescent cell anti-apoptotic pathways (SCAPs), which defend those SCs that are pro-apoptotic and pro-inflammatory from their own senescence(definition)-associated secretory phenotype (SASP). Consistent with this, a JAK/STAT inhibitor, Ruxolitinib, which attenuates the pro-inflammatory SASP of senescent human preadipocytes, caused them to become “senolytic-resistant”. Administering senolytics to obese mice selectively decreased abundance of the subset of SCs that is pro-inflammatory. In cell cultures, the 30-70% of human senescent preadipocytes or human umbilical vein endothelial cells (HUVECs) that are senolytic-resistant (to Dasatinib or Quercetin, respectively) had increased p16 INK4a , p21 CIP1 , senescence-associated β-galactosidase (SAβgal), γH2AX, and proliferative arrest similarly to the total SC population (comprising senolytic-sensitive plus -resistant SCs). However, the SASP of senolytic-resistant SCs entailed less pro-inflammatory/ apoptotic factor production, induced less inflammation in non-senescent cells, and was equivalent or richer in growth/ fibrotic factors. Senolytic-resistant SCs released less mitochondrial DNA (mtDNA) and more highly expressed the anti-inflammatory immune evasion signal, glycoprotein non-melanoma-B (GPNMB). Transplanting senolytic-resistant SCs intraperitoneally into younger mice caused less physical dysfunction than transplanting the total SC population. Because Ruxolitinib attenuates SC release of pro-apoptotic SASP factors, while pathogen-associated molecular pattern factors (PAMPs) can amplify the release of these factors rapidly (acting as “senosensitizers”), senolytic-resistant and senolytic-sensitive SCs appear to be interconvertible.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2025.08.27.672709
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Tripathi, U., Suda, M., Kulshreshtha, V., Piatkowski, B.T., Palmer, A.K., Giorgadze, N., Inman, C.L., Gasek, N.S., Xu, M., Johnson, K.O., Pirtskhalava, T., Chaib, S., Prata, L.G.P.L., Zhu, Y.Z., Kandhaya‐Pillai, R., Tullius, S.G., Wyles, S.P., Majji, R., Yalamanchili, H.K., & Allison, D.B. (2025). Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2025.08.27.672709
Vancouver
Tripathi U, Suda M, Kulshreshtha V, Piatkowski BT, Palmer AK, Giorgadze N, et al. Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers. bioRxiv (Cold Spring Harbor Laboratory). 2025. doi:10.1101/2025.08.27.672709.
BibTeX
@unpublished{utkarsh2025Senoly,
title = {Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers},
author = {Utkarsh Tripathi and Masayoshi Suda and Vagisha Kulshreshtha and Bryan Thomas Piatkowski and Allyson K. Palmer and Nino Giorgadze and Christina L. Inman and Nathan S. Gasek and Ming Xu and Kurt O. Johnson and Tamar Pirtskhalava and Selim Chaib and Larissa G. P. Langhi Prata and Yi Zhun Zhu and Renuka Kandhaya‐Pillai and Stefan G. Tullius and Saranya P. Wyles and Rambabu Majji and Hari Krishna Yalamanchili and David Blair Allison and Tamar Tchkonia and James L. Kirkland},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2025},
doi = {10.1101/2025.08.27.672709},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2026
Open access · OA
Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers.
Aging Cell 2025
Open access · CC-BY
Senolytic‐Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers
Science Translational Medicine 2023
Open access · OA
NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates
Geromedicine 2026
Open access · CC-BY
Senescent cell heterogeneity: The impact of targeting senescent endothelial cells in obesity
Journal of Neurochemistry 2023
Open access · CC-BY
Characterizing microglial senescence: Tau as a key player
Journal of the European Academy of Dermatology and Venereology 2024
Open access · OA